Q-omics provides the consensus-scored BAIAP3 profile across patient tissues and cancer cell-line models. BAIAP3 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, BAIAP3 is differentially expressed in 8, with the highest sampling consensus in THCA. Additionally, BAIAP3 RNA expression shows 17,139 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight COAD, THCA, and THYM as cancer lineages where BAIAP3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for BAIAP3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes BAIAP3 survival associations across molecular data types. BAIAP3 RNA expression shows survival associations in the most cancer types (21), followed by mutation status (10) and mass-spec protein abundance (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible BAIAP3 RNA expression–survival associations across cancer types. High BAIAP3 expression shows unfavorable associations in COAD, ACC, UCS and KIRP, but favorable associations in KIRC and BRCA. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify COAD as the clearest survival context for BAIAP3 RNA expression.
This table summarizes BAIAP3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8, while mass-spec protein shows differences in 2. The strongest signals are observed in THCA for RNA and PDAC for protein.
This table ranks reproducible tumor–normal expression differences for BAIAP3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. BAIAP3 shows lower tumor expression in KIRC, LUSC, ESCA and KIRP and higher tumor expression in THCA and PAAD. The THCA box plot shows higher BAIAP3 RNA expression in tumor versus normal tissue (log2 FC = +3.300, t-test p < 0.001).
This table shows molecular features associated with BAIAP3 in patient tissues and cancer cell lines. In patient samples, BAIAP3 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set. In cancer cell lines, BAIAP3 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LIVER, while CRISPR and shRNA rows add functional-dependency signals in SKIN and UPPER_AERODIGESTIVE_TRACT.
